PG

Paul Grayson

President and CEO of Radionetics Oncology

San Diego, California

Overview

Work Experience

RO

Radionetics Oncology

  • President and CEO

    2024 - Current

TB

Tentarix Biotherapeutics, Inc.

  • President and CEO

    2020 - 2024

    Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage powerful synergistic biology. On an unprecedented scale, we are leading a fundamental change in the methods of discovery and engineering of multi-specific biologics.

VV

Versant Ventures

  • Venture Partner

    2019 - 2024

BR

Bird Rock Bio, Inc.

  • President and CEO

    2011 - 2024

FT

Fate Therapeutics Inc

  • President and CEO

    2008 - 2011

SV

Sanderling Ventures

  • Managing Director

    2003 - 2008

Senomyx, Inc.

  • President, CEO, Chairman and Founder

    1999 - 2003

Aurora BioSciences, Inc.

  • Senior Vice President, Corporate Development

    1996 - 1999

Education

Investments

Tentarix Biotherapeutics

Series A

Total Funding: $85M

Pipeline Therapeutics

Series B

Total Funding: $110M

Taligen Therapeutics

Series B

Total Funding: $79M

Relevant Websites